Your browser doesn't support javascript.
loading
Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.
Koike, Junichi; Funahashi, Kimihiko; Yoshimatsu, Kazuhiko; Yokomizo, Hajime; Kan, Hayato; Yamada, Takeshi; Ishida, Hideyuki; Ishibashi, Keiichiro; Saida, Yoshihisa; Enomoto, Toshiyuki; Katsumata, Kenji; Hisada, Masayuki; Hasegawa, Hirotoshi; Koda, Keiji; Ochiai, Takumi; Sakamoto, Kazuhiro; Shiokawa, Hiroyuki; Ogawa, Shimpei; Itabashi, Michio; Kameoka, Shingo.
Afiliação
  • Koike J; Department of Gastroenterological Surgery, Omori Medical Center, Toho University School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan. jkoike18@med.toho-u.ac.jp.
  • Funahashi K; FACT Trial Group, Tokyo, Japan. jkoike18@med.toho-u.ac.jp.
  • Yoshimatsu K; Department of Gastroenterological Surgery, Omori Medical Center, Toho University School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan.
  • Yokomizo H; FACT Trial Group, Tokyo, Japan.
  • Kan H; Department of Surgery, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Yamada T; FACT Trial Group, Tokyo, Japan.
  • Ishida H; Department of Surgery, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Ishibashi K; FACT Trial Group, Tokyo, Japan.
  • Saida Y; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
  • Enomoto T; FACT Trial Group, Tokyo, Japan.
  • Katsumata K; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
  • Hisada M; FACT Trial Group, Tokyo, Japan.
  • Hasegawa H; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Koda K; FACT Trial Group, Tokyo, Japan.
  • Ochiai T; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Sakamoto K; FACT Trial Group, Tokyo, Japan.
  • Shiokawa H; Department of Surgery, Toho University Ohashi Medical Center, Tokyo, Japan.
  • Ogawa S; FACT Trial Group, Tokyo, Japan.
  • Itabashi M; Department of Surgery, Toho University Ohashi Medical Center, Tokyo, Japan.
  • Kameoka S; FACT Trial Group, Tokyo, Japan.
Cancer Chemother Pharmacol ; 79(3): 519-525, 2017 03.
Article em En | MEDLINE | ID: mdl-28150022
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article